• Collaborate with key stakeholders to execute a comprehensive investor relations strategy aligned with corporate objectives and long-term value creation. • Articulate a clear and compelling investment thesis that integrates scientific rationale, clinical data, regulatory strategy, and financial outlook. • Lead preparation of earnings materials, investor presentations, fact sheets, Q&A documents, and corporate messaging. • Keep track of investor interactions, organize meetings, and coordinate presence at investor conferences including developing a strategy for identifying and meeting a target list of investors. • Oversee investor-facing sections of press releases, SEC filings, and the corporate website for consistency and accuracy. • Serve as a primary point of contact for institutional investors, analysts, and proxy advisory firms. • Manage earnings calls, investor days, conference participation, non-deal roadshows, and one-on-one investor meetings. • Build and maintain strong relationships with sell-side analysts to ensure accurate coverage. • Partner with Finance, Legal, and external advisors to ensure compliance with SEC regulations and Reg FD requirements. • Monitor peer activity, valuation trends, sell-side price targets & valuation models, and industry developments within the biotech and life sciences sector. • Approximately 25% travel, including investor conferences, roadshows, and meetings.